These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30026784)

  • 1. Changes in lysophospholipids and liver status after weight loss: the RESMENA study.
    Cantero I; Abete I; Del Bas JM; Caimari A; Arola L; Zulet MA; Martinez JA
    Nutr Metab (Lond); 2018; 15():51. PubMed ID: 30026784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fruit Fiber Consumption Specifically Improves Liver Health Status in Obese Subjects under Energy Restriction.
    Cantero I; Abete I; Monreal JI; Martinez JA; Zulet MA
    Nutrients; 2017 Jun; 9(7):. PubMed ID: 28657604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study.
    Perez-Diaz-Del-Campo N; Marin-Alejandre BA; Cantero I; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Riezu-Boj JI; Milagro FI; Tur JA; Martinez JA; Abete I; Zulet MA
    Eur J Nutr; 2021 Sep; 60(6):3043-3057. PubMed ID: 33474638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three Different Genetic Risk Scores Based on Fatty Liver Index, Magnetic Resonance Imaging and Lipidomic for a Nutrigenetic Personalized Management of NAFLD: The Fatty Liver in Obesity Study.
    Perez-Diaz-Del-Campo N; Riezu-Boj JI; Marin-Alejandre BA; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Milagro FI; Tur JA; Abete I; Zulet MA; Martinez JA
    Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34199237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American Heart Association (AHA) guidelines: the MEtabolic Syndrome REduction in NAvarra (RESMENA) project.
    de la Iglesia R; Lopez-Legarrea P; Abete I; Bondia-Pons I; Navas-Carretero S; Forga L; Martinez JA; Zulet MA
    Br J Nutr; 2014 Feb; 111(4):643-52. PubMed ID: 23968597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay of atherogenic factors, protein intake and betatrophin levels in obese-metabolic syndrome patients treated with hypocaloric diets.
    Crujeiras AB; Zulet MA; Abete I; Amil M; Carreira MC; Martínez JA; Casanueva FF
    Int J Obes (Lond); 2016 Mar; 40(3):403-10. PubMed ID: 26443337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: the RESMENA randomized controlled trial.
    Lopez-Legarrea P; de la Iglesia R; Abete I; Bondia-Pons I; Navas-Carretero S; Forga L; Martinez JA; Zulet MA
    Nutr Metab (Lond); 2013 Feb; 10(1):22. PubMed ID: 23406163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipidomic Profile Revealed the Association of Plasma Lysophosphatidylcholines with Adolescent Obesity.
    Wang Y; Jiang CT; Song JY; Song QY; Ma J; Wang HJ
    Biomed Res Int; 2019; 2019():1382418. PubMed ID: 31915678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.
    Aller R; Izaola O; Gómez S; Tafur C; González G; Berroa E; Mora N; González JM; de Luis DA
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3118-24. PubMed ID: 26367736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of plasma lysophosphatidylcholine species in obesity and weight loss.
    Heimerl S; Fischer M; Baessler A; Liebisch G; Sigruener A; Wallner S; Schmitz G
    PLoS One; 2014; 9(10):e111348. PubMed ID: 25340546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary Inflammatory Index and liver status in subjects with different adiposity levels within the PREDIMED trial.
    Cantero I; Abete I; Babio N; Arós F; Corella D; Estruch R; Fitó M; Hebert JR; Martínez-González MÁ; Pintó X; Portillo MP; Ruiz-Canela M; Shivappa N; Wärnberg J; Gómez-Gracia E; Tur JA; Salas-Salvadó J; Zulet MA; Martínez JA
    Clin Nutr; 2018 Oct; 37(5):1736-1743. PubMed ID: 28734553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
    Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
    Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of the RESMENA dietary pattern on oxidative stress in patients suffering from metabolic syndrome with hyperglycemia are associated to dietary TAC and fruit consumption.
    de la Iglesia R; Lopez-Legarrea P; Celada P; Sánchez-Muniz FJ; Martinez JA; Zulet MA
    Int J Mol Sci; 2013 Mar; 14(4):6903-19. PubMed ID: 23535332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Simple obesity in children. A study on the role of nutritional factors].
    Weker H
    Med Wieku Rozwoj; 2006; 10(1):3-191. PubMed ID: 16733288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.
    Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal relationship of diet and oxidative stress with depressive symptoms in patients with metabolic syndrome after following a weight loss treatment: the RESMENA project.
    Perez-Cornago A; Lopez-Legarrea P; de la Iglesia R; Lahortiga F; Martinez JA; Zulet MA
    Clin Nutr; 2014 Dec; 33(6):1061-7. PubMed ID: 24314875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 21 levels and liver inflammatory biomarkers in obese subjects after weight loss.
    Cantero I; Abete I; Bullón-Vela V; Crujeiras AB; Casanueva FF; Zulet MA; Martinez JA
    Arch Med Sci; 2022; 18(1):36-44. PubMed ID: 35154523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reduction of the metabolyc syndrome in Navarra-Spain (RESMENA-S) study: a multidisciplinary strategy based on chrononutrition and nutritional education, together with dietetic and psychological control.
    Zulet MA; Bondia-Pons I; Abete I; de la Iglesia R; López-Legarrea P; Forga L; Navas-Carretero S; Martínez JA
    Nutr Hosp; 2011; 26(1):16-26. PubMed ID: 21519726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in glycaemic status do not predict weight loss in response to hypocaloric diets in obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
    Clin Nutr; 2006 Feb; 25(1):117-22. PubMed ID: 16278036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.